DESIGN OF EXPERIMENT IN MODERN DRUG DELIVERY: OPTIMIZATION OF LIPID-BASED FORMULATION USING DESIGN-EXPERT

Authors

  • Ankita Adhikari Himalayan Pharmacy Institute, Majhitar, Sikkim, India -737136
  • Pragya Baghel Himalayan Pharmacy Institute, Majhitar, Sikkim, India-737136
  • Sanjib Bahadur Himalayan Pharmacy Institute, Majhitar, Sikkim, India -737136

DOI:

https://doi.org/10.61114/UJPSR.10.2.2026.10-20

Keywords:

Design of Experiments (DoE), Design-Expert software, Quality by Design (QbD), Response Surface Methodology, Box–Behnken design, Central Composite Design, Lipid-based drug delivery systems, Solid lipid nanoparticles (SLN)

Abstract

Design of Experiments (DOE) has become integral to pharmaceutical development, providing a systematic alternative to conventional one-factor-at-a-time approaches. DOE enables simultaneous evaluation of multiple variables, identification of interaction effects, and efficient formulation optimization and process parameter optimization. Design-Expert software supports this methodology through structured experimental design, statistical modeling, analysis of variance, and response surface visualization, facilitating data-driven decision-making. This review highlights the application of Design–Expert–assisted DOE in pharmaceutical formulation, focusing on factorial designs, Box-Behnken design (BBD), central composite design (CCD), and mixture designs. These approaches are extensively used to optimize critical quality attributes in both conventional dosage forms and advanced drug delivery platforms, including self-emulsifying (SEDDS), self-micro-emulsifying (SMEDDS), self-nanoemulsifying systems (SNEDDS), and solid lipid nanoparticles. Response surface methodology facilitates the development of quadratic models and desirability-based optimization. The applications reviewed demonstrate improved process understanding, enhanced bioavailability of poorly water-soluble drugs, and reproducible product performance. Overall, design–expert–driven DOE provides a powerful and reliable framework for rational pharmaceutical development, accelerating optimization while aligning with regulatory expectations for systematic, science-based product design.

References

1. Dhoot AS, Fernandes GJ, Naha A, Rathnanand M, Kumar L. Design of Experiments in Pharmaceutical Development. Pharm Chem J. 2019 Nov 1;53(8):730–5. doi:10.1007/s11094-019-02070-4

2. Serrano ACCL, Viana MC, Pinto NV, Lages EB, Carneiro G, Borges GSM. The Use of Design of Experiments (DoE) Approaches for the Development of Self-Emulsifying Drug Delivery Systems (SEDDS). Appl Nano. 2025 Feb 12;6(1):4. doi:10.3390/applnano6010004

3. Singh B, Kapil R, Nandi M, Ahuja N. Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects. Expert Opin Drug Deliv. 2011 Oct;8(10):1341–60. doi:10.1517/17425247.2011.605120

4. Ahad HA, Chinthaginjala H, Tarun K, Reddy GG, Adam AAO, Ali AI, et al. Hylocereus undatus fruit extraction on percent yield using Design-Expert software: a revelation for the enormousness of temperature and contact time. Egypt Pharm J. 2023 Jan;22(1):49–53. doi:10.4103/epj.epj_97_22

5. Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding Pharmaceutical Quality by Design. AAPS J. 2014 May 23;16(4):771–83. doi:10.1208/s12248-014-9598-3 PubMed PMID: 24854893; PubMed Central PMCID: PMC4070262.

6. Zhang L, Mao S. Application of quality by design in the current drug development. Asian J Pharm Sci. 2017 Jan;12(1):1–8. doi:10.1016/j.ajps.2016.07.006 PubMed PMID: 32104308; PubMed Central PMCID: PMC7032183.

7. Türkdoğan A, Alloush T, Demiralp B. Experimental Design in Pharmaceutical Formulation Development: Achievements, Limitations and the Transition Toward Intelligent Optimization. Sci Pharm. 2026 May 13;94(2):38. doi:10.3390/scipharm94020038

8. Salazar J, Heinzerling O, Müller RH, Möschwitzer JP. Process optimization of a novel production method for nanosuspensions using design of experiments (DoE). Int J Pharm. 2011 Nov;420(2):395–403. doi:10.1016/j.ijpharm.2011.09.003

9. Zhou YZ, Alany RG, Chuang V, Wen J. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design. Drug Dev Ind Pharm. 2013 Feb;39(2):321–30. doi:10.3109/03639045.2012.681054

10. Rezić I. Prediction of the surface tension of surfactant mixtures for detergent formulation using Design Expert software. Monatshefte Für Chem - Chem Mon. 2011 Dec;142(12):1219–25. doi:10.1007/s00706-011-0554-y

11. Khoshyari S, Mahjub R. Preparation, Box-Behnken Statistical Optimization, and In Vitro Characterization of a Self-nanoemulsifying Drug Delivery System for the Oral Delivery of Budesonide as a Poorly Soluble Drug. Avicenna J Pharm Res. 2020 Jul 6;1(1):24–32. doi:10.34172/ajpr.2020.05

12. Hsieh CM, Yang TL, Putri AD, Chen CT. Application of Design of Experiments in the Development of Self-Microemulsifying Drug Delivery Systems. Pharmaceuticals. 2023 Feb;16(2):283. doi:10.3390/ph16020283

13. Agrawal A, Dudhedia M, Deng W, Shepard K, Zhong L, Povilaitis E, et al. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach. AAPS PharmSciTech. 2016 Feb;17(1):214–32. doi:10.1208/s12249-015-0472-0

14. Tye H. Application of statistical ‘design of experiments’ methods in drug discovery. Drug Discov Today. 2004 Jun;9(11):485–91. doi:10.1016/S1359-6446(04)03086-7

15. Challa TR, Reshma K. Experimental Design Statistically by Design Expert Software: A Model Poorly Soluble Drug with Dissolution Enhancement and Optimization. Int J DRUG Deliv Technol. 2022 Jun 30;12(03):1367–75. doi:10.25258/ijddt.12.3.72

16. Alben KT. Books and Software: Design, analyze, and optimize with Design-Expert. Anal Chem. 2002 Apr 1;74(7):222 A-223 A. doi:10.1021/ac0219703

17. Rahul AV, Santhanam M, Meena H, Ghani Z. 3D printable concrete: Mixture design and test methods. Cem Concr Compos. 2019 Mar;97:13–23. doi:10.1016/j.cemconcomp.2018.12.014

18. Na YG, Byeon JJ, Wang M, Huh HW, Kim MK, Bang KH, et al. Statistical approach for solidifying ticagrelor loaded self-microemulsifying drug delivery system with enhanced dissolution and oral bioavailability. Mater Sci Eng C. 2019 Nov;104:109980. doi:10.1016/j.msec.2019.109980

19. Fang HB, Chen X, Pei XY, Grant S, Tan M. Experimental design and statistical analysis for three-drug combination studies. Stat Methods Med Res. 2017 Jun;26(3):1261–80. doi:10.1177/0962280215574320

20. Abhyankar MM, Orr MT, Kinsey R, Sivananthan S, Nafziger AJ, Oakland DN, et al. Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy. Front Immunol. 2021 Jun 25;12:683157. doi:10.3389/fimmu.2021.683157

21. H. Shariare M, Afnan K, Iqbal F, A. Altamimi M, Ahamad SR, S. Aldughaim M, et al. Development and Optimization of Epigallocatechin-3-Gallate (EGCG) Nano Phytosome Using Design of Experiment (DoE) and Their In Vivo Anti-Inflammatory Studies. Molecules. 2020 Nov 20;25(22):5453. doi:10.3390/molecules25225453

22. Solanki HK, Shah DA. Formulation Optimization and Evaluation of Probiotic Lactobacillus sporogenes-Loaded Sodium Alginate with Carboxymethyl Cellulose Mucoadhesive Beads Using Design Expert Software. J Food Process. 2016;2016(1):6041671. doi:10.1155/2016/6041671

23. Chowdary KPR, Ravi Shankar K. Optimization of Pharmaceutical Product Formulation by Factorial Designs: Case Studies. J Pharm Res. 2016 Dec 1;15(4):105. doi:10.18579/jpcrkc/2016/15/4/108815

24. Hsieh CM, Yang TL, Putri AD, Chen CT. Application of Design of Experiments in the Development of Self-Microemulsifying Drug Delivery Systems. Pharmaceuticals. 2023 Feb 13;16(2):283. doi:10.3390/ph16020283

25. Pramod K, Tahir MA, Charoo NA, Ansari SH, Ali J. Pharmaceutical product development: A quality by design approach. Int J Pharm Investig. 2016;6(3):129–38. doi:10.4103/2230-973X.187350 PubMed PMID: 27606256; PubMed Central PMCID: PMC4991121.

26. Kuncahyo I, Choiri S, Fudholi A, Martien R, Rohman A. Assessment of Fractional Factorial Design for the Selection and Screening of Appropriate Components of a Self-nanoemulsifying Drug Delivery System Formulation. Adv Pharm Bull. 2019 Oct;9(4):609–18. doi:10.15171/apb.2019.070 PubMed PMID: 31857965; PubMed Central PMCID: PMC6912180.

27. Sopyan I, Gozali D, K. S. IS, Guntina RK. OVERVIEW OF PECTIN AS AN EXCIPIENT AND ITS USE IN THE PHARMACEUTICAL DOSAGE FORM. Int J Appl Pharm. 2022 Jul 7;64–70. doi:10.22159/ijap.2022v14i4.45091

28. Du Y, Huang P, Jin W, Li C, Yang J, Wan H, et al. Optimization of Extraction or Purification Process of Multiple Components from Natural Products: Entropy Weight Method Combined with Plackett–Burman Design and Central Composite Design. Molecules. 2021 Sep 14;26(18):5572. doi:10.3390/molecules26185572

29. Bose A, Wong TW, Singh N. Formulation development and optimization of sustained release matrix tablet of Itopride HCl by response surface methodology and its evaluation of release kinetics. Saudi Pharm J. 2013 Apr;21(2):201–13. doi:10.1016/j.jsps.2012.03.006

30. Srabani Podder, Sudipta Mukherjee. RESPONSE SURFACE METHODOLOGY (RSM) AS A TOOL IN PHARMACEUTICAL FORMULATION DEVELOPMENT. Asian J Pharm Clin Res. 2024 Nov 7;18–25. doi:10.22159/ajpcr.2024v17i11.52149

31. Bushra R, Shoaib MH, Ali H, Zafar F, Naeem MI, Aslam N, et al. Formulation Design and Optimization of Aceclofenac Tablets (100 mg) Using Central Composite Design with Response Surface Methodology. Lat Am J Pharm. 2014.

32. Chinthaginjala H, Ahad HA, Bhargav E, Pradeepkumar B. Central Composite Design Aided Formulation Development and Optimization of Clarythromycin Extended-Release Tablets. Indian J Pharm Educ Res. 2021 May 17;55(2):395–406. doi:10.5530/ijper.55.2.77

33. Kumar DS, Bhavitha K, Harani A, Meenakshi V, Rajendran P, Lee IE, et al. Green analytical comparison and central composite design optimization for simultaneous estimation of pain management drugs using RP-liquid chromatography. Microchem J. 2025 Jan;208:112309. doi:10.1016/j.microc.2024.112309

34. Shivakumar HN, Patel R, Desai BG. Formulation Optimization of Propranolol Hydrochloride Microcapsules Employing Central Composite Design. Indian J Pharm Sci. 2008;70(3):408–13. doi:10.4103/0250-474X.43024 PubMed PMID: 20046763; PubMed Central PMCID: PMC2792503.

35. Singh G, Pai R, Devi Vk. Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design. J Adv Pharm Technol Res. 2012;3(1):30. doi:10.4103/2231-4040.93565

36. Narukulla S, Bogadi S, Tallapaneni V, Sanapalli BKR, Sanju S, Khan AA, et al. Comparative study between the Full Factorial, Box–Behnken, and Central Composite Designs in the optimization of metronidazole immediate release tablet. Microchem J. 2024 Dec;207:111875. doi:10.1016/j.microc.2024.111875

37. Gulia R, Singh S, Arora S, Sharma N. Development and optimization of Hydrotropic Solid Dispersion of Dexlansoprazole using Central Composite Design approach.

38. Szpisják-Gulyás N, Al-Tayawi AN, Horváth ZsH, László Zs, Kertész Sz, Hodúr C. Methods for experimental design, central composite design and the Box–Behnken design, to optimise operational parameters: A review. Acta Aliment. 2023 Dec 4;52(4):521–37. doi:10.1556/066.2023.00235

39. Yadav P, Rastogi V, Verma A. Application of Box–Behnken design and desirability function in the development and optimization of self-nanoemulsifying drug delivery system for enhanced dissolution of ezetimibe. Future J Pharm Sci. 2020 Dec;6(1):7. doi:10.1186/s43094-020-00023-3

40. Akram W, Garud N. Design expert as a statistical tool for optimization of 5-ASA-loaded biopolymer-based nanoparticles using Box Behnken factorial design. Future J Pharm Sci. 2021 Dec;7(1):146. doi:10.1186/s43094-021-00299-z

41. Xinsheng Peng, Fang. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int J Nanomedicine. 2011 Apr;683. doi:10.2147/IJN.S17386

42. Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm. 2002 Jun;240(1–2):103–14. doi:10.1016/S0378-5173(02)00130-8

43. El-Shenawy AA, Ahmed MM, Mansour HF, Abd El Rasoul S. Torsemide Fast Dissolving Tablets: Development, Optimization Using Box–Bhenken Design and Response Surface Methodology, In Vitro Characterization, and Pharmacokinetic Assessment. AAPS PharmSciTech. 2017 Aug;18(6):2168–79. doi:10.1208/s12249-016-0697-6

44. Samy AM, Ramadan AA, Abu El-enin AS m., Mortagi YIM. FORMULATION AND OPTIMIZATION OF ITRACONAZOLE PRONIOSOMES USING BOX BEHNKEN DESIGN. Int J Appl Pharm. 2018 Mar 7;10(2):41. doi:10.22159/ijap.2018v10i2.23382

45. Basha DC, Sudha BN. Box Behnken’s Design of Fast-Dissolving Ondansetron Buccal Films and Assessing the Impact of Independent Variables on their Swelling and Folding Endurance Constraints. Indian J Pharm Educ Res. 2024 May 28;58(2s):s412–9. doi:10.5530/ijper.58.2s.44

46. Sukhbir S, Yashpal S, Sandeep A. Development and statistical optimization of nefopam hydrochloride loaded nanospheres for neuropathic pain using Box–Behnken design. Saudi Pharm J. 2016 Sep;24(5):588–99. doi:10.1016/j.jsps.2015.03.020

47. Fayza Baghli, Djawad Chikh, Nassima Moussaoui-Khedam. Box–Behnken design for the development of fluconazole-loaded classical ethosomes. GSC Biol Pharm Sci. 2024 Sep 30;28(3):057–70. doi:10.30574/gscbps.2024.28.3.0316

48. Choi YW, Yeom DW, Song YS, Kim SR, Lee SG, Kang MH, et al. Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design. Int J Nanomedicine. 2015 Jun;3865. doi:10.2147/IJN.S83520

49. Campisi B, Chicco D, Vojnovic D, Phan-Tan-Luu R. Experimental design for a pharmaceutical formulation: optimisation and robustness. J Pharm Biomed Anal. 1998 Oct;18(1–2):57–65. doi:10.1016/S0731-7085(98)00175-7

50. Ogbonna JDN, Attama AA, Ofokansi KC, Patil SB, Basarkar GD. Optimization of formulation processes using Design Expert ® Software for preparation of polymeric blends-artesunate-amodiaquine HCl microparticles. J Drug Deliv Sci Technol. 2017 Jun;39:36–49. doi:10.1016/j.jddst.2017.02.011

51. Desai PP, Date AA, Patravale VB. Overcoming poor oral bioavailability using nanoparticle formulations – opportunities and limitations. Drug Discov Today Technol. 2012 Jun;9(2):e87–95. doi:10.1016/j.ddtec.2011.12.001

52. Baek JS, Cho CW. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake. Eur J Pharm Biopharm. 2017 Aug;117:132–40. doi:10.1016/j.ejpb.2017.04.013

53. Ogbonna JDN, Attama AA, Ofokansi KC, Patil SB, Basarkar GD. Optimization of formulation processes using Design Expert ® Software for preparation of polymeric blends-artesunate-amodiaquine HCl microparticles. J Drug Deliv Sci Technol. 2017 Jun;39:36–49. doi:10.1016/j.jddst.2017.02.011

54. Krstić M, Medarević Đ, Đuriš J, Ibrić S. Self-nanoemulsifying drug delivery systems (SNEDDS) and self-microemulsifying drug delivery systems (SMEDDS) as lipid nanocarriers for improving dissolution rate and bioavailability of poorly soluble drugs. In: Lipid Nanocarriers for Drug Targeting [Internet]. Elsevier; 2018 [cited 2025 Aug 27]. p. 473–508. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128136874000128 doi:10.1016/B978-0-12-813687-4.00012-8

55. Pawar SD, Gujarathi NA, Rane BR, Pawar SP. SELF-MICRO EMULSIFYING DRUG DELIVERY SYSTEM (SMEDDS): A PROMISING DRUG DELIVERY SYSTEM FOR ENHANCEMENT OF BIOAVAILABILITY. 2016.

56. Yandi Syukri, Syafira Tri Nurmala Sari, Arba Pramundita Ramadani. A Comprehensive Review of Solid Self Nano Emulsifying Drug Delivery System (S-SNEDDS) Technology to Enhance Nanoemulsion Stability. J Sains Farm Klin. 2025 Jul 1;12(1):15–28. doi:10.25077/jsfk.12.1.15-28.2025

57. Kyatanwar AU, Jadhav KR, Kadam VJ. Self micro-emulsifying drug delivery system (SMEDDS) : Review. J Pharm Res. 2010;(1).

58. Rehman FU, Farid A, Shah SU, Dar MJ, Rehman AU, Ahmed N, et al. Self-Emulsifying Drug Delivery Systems (SEDDS): Measuring Energy Dynamics to Determine Thermodynamic and Kinetic Stability. Pharmaceuticals. 2022 Aug 26;15(9):1064. doi:10.3390/ph15091064

59. UYANIKGİL PDEÖÇ, Taşkıran A, Erışık D, Çalışkan EE, Demirtürk E, Aydın YÇ, et al. ADVANCED DRUG DELIVERY TECHNOLOGIES. Bzt Turan Publishing House; 2025. 93 p.

60. Kumar A, Sharma S, Kamble R. SELF EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS): FUTURE ASPECTS. Vol. 2. 2.

61. Kale AA, Patravale VB. Design and Evaluation of Self-Emulsifying Drug Delivery Systems (SEDDS) of Nimodipine. AAPS PharmSciTech. 2008 Feb 5;9(1):191–6. doi:10.1208/s12249-008-9037-9 PubMed PMID: 18446481; PubMed Central PMCID: PMC2976914.

62. Bernkop-Schnürch A, Jalil A. Do drug release studies from SEDDS make any sense? J Controlled Release. 2018 Feb;271:55–9. doi:10.1016/j.jconrel.2017.12.027

63. Neslihan Gursoy R, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004 Apr;58(3):173–82. doi:10.1016/j.biopha.2004.02.001

64. Serrano ACCL, Viana MC, Pinto NV, Lages EB, Carneiro G, Borges GSM. The Use of Design of Experiments (DoE) Approaches for the Development of Self-Emulsifying Drug Delivery Systems (SEDDS). Appl Nano. 2025 Mar;6(1):4. doi:10.3390/applnano6010004

65. Nigade PM, Patil SL, Tiwari SS. SELF EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS): A Review. Int J Pharm Biol Sci. 2(2).

66. Singh B, Bandopadhyay S, Kapil R, Singh R, Katare OP. Self-Emulsifying Drug Delivery Systems (SEDDS): Formulation Development, Characterization, and Applications. Crit Rev Ther Drug Carrier Syst. 2009;26(5):427–51. doi:10.1615/CritRevTherDrugCarrierSyst.v26.i5.10

67. Jha D, Sindhu K, Kumar A, Utwaliya GK, Ranjan H, Kumari N, et al. Optimization of Advance Novel Oral Self-Emulsifying Drug Delivery System (SEDDs) Involving Box-Behnken Design as Statistical Analysis Approach of Nateglinide Drug. J Neonatal Surg. 2025;14(23).

68. Krstić MZ, Ražić SS, Djekić LM, Dobričić VD, Momčilović MA, Vasiljević DD, et al. Application of a Mixture Experimental Design in the Optimization of the Formulation of Solid Self-Emulsifying Drug Delivery Systems Containing Carbamazepine. Lat Am J Pharm. 2015.

69. Dokania S, Joshi AK. Self-microemulsifying drug delivery system (SMEDDS) – challenges and road ahead. Drug Deliv. 2015 Aug 18;22(6):675–90. doi:10.3109/10717544.2014.896058

70. Emad NA, Sultana Y, Aqil M, Saleh A, Al Kamaly O, Nasr FA. Omega-3 fatty acid-based self-microemulsifying drug delivery system (SMEDDS) of pioglitazone: Optimization, in vitro and in vivo studies. Saudi J Biol Sci. 2023 Sep;30(9):103778. doi:10.1016/j.sjbs.2023.103778

71. Borhade V, Nair H, Hegde D. Design and Evaluation of Self-Microemulsifying Drug Delivery System (SMEDDS) of Tacrolimus. AAPS PharmSciTech. 2008 Mar;9(1):13–21. doi:10.1208/s12249-007-9014-8

72. Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004 Apr;274(1–2):65–73. doi:10.1016/j.ijpharm.2003.12.028

73. Maurya SD, Arya RK, Rajpal G, Dhakar RC. SELF-MICRO EMULSIFYING DRUG DELIVERY SYSTEMS (SMEDDS): A REVIEW ON PHYSICO-CHEMICAL AND BIOPHARMACEUTICAL ASPECTS. J Drug Deliv Ther. 2017 May 15;7(3):55–65. doi:10.22270/jddt.v7i3.1453

74. Kumari PVK, Likhitha G, Hussain Mustaq SJ. APPROACH TO OPTIMIZE THE SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM FOR AZILSARTAN MEDOXOMIL USING BOX BEHNKEN DESIGN AND DESIRABILITY FUNCTION. Int J Appl Pharm. 2024 Mar 7;92–100. doi:10.22159/ijap.2024v16i2.49519

75. Parakh DR, Patil MP, Sonawane SS, Kshirsagar SJ. Application of factorial design approach in development and evaluation of self microemulsifying drug delivery system (SMEDDS) of mebendazole. J Pharm Investig. 2017 Nov;47(6):507–19. doi:10.1007/s40005-016-0279-3

76. Bhattacharya S, Mishra S, Prajapati BG. Design and Development of Docetaxel Solid Self-Microemulsifying Drug Delivery System Using Principal Component Analysis and D-Optimal Design.

77. MAHORE-Aniket SHELAR-Sanjeevani Deshkar J. Conceptual design and optimization of self microemulsifying drug delivery systems for dapsone by using Box-Behnken design. J Res Pharm. 2021;25(2)(25(2)):179–95. doi:10.29228/jrp.9

78. Indrati O, Martien R, Rohman A, Nugroho AK. Application of Simplex Lattice Design on the Optimization of Andrographolide Self Nanoemulsifying Drug Delivery System (SNEDDS). Indones J Pharm. 2020 Jul 10;31(2):124. doi:10.14499/indonesianjpharm31iss2pp124

79. Altamimi MA, Kazi M, Hadi Albgomi M, Ahad A, Raish M. Development and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for curcumin transdermal delivery: an anti-inflammatory exposure. Drug Dev Ind Pharm. 2019 Jul 3;45(7):1073–8. doi:10.1080/03639045.2019.1593440

80. Kim JO, Rashid R, Kim DW, Yousaf AM, Mustapha O, Din FU, et al. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe. Int J Nanomedicine. 2015 Sep;6147. doi:10.2147/IJN.S91216

81. Kazi M, Al-Swairi M, Ahmad A, Raish M, Alanazi FK, Badran MM, et al. Evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Poorly Water-Soluble Talinolol: Preparation, in vitro and in vivo Assessment. Front Pharmacol. 2019 May 2;10:459. doi:10.3389/fphar.2019.00459

82. Priani SE, Fakih TM, Wilar G, Chaerunisaa AY, Sopyan I. Quality by Design and In Silico Approach in SNEDDS Development: A Comprehensive Formulation Framework. Pharmaceutics. 2025 May 27;17(6):701. doi:10.3390/pharmaceutics17060701

83. Sahare PS, Sheth ZP, Shaha A, Kondrapu P, Rakhamaji A, Mehta FF, et al. Formulation, Optimization and Evaluation of Poorly Soluble Drug Snedds. J Neonatal Surg. 2025;14(7).

84. Liao H, Gao Y, Lian C, Zhang Y, Wang B, Yang Y, et al. Oral absorption and lymphatic transport of baicalein following drug–phospholipid complex incorporation in self-microemulsifying drug delivery systems. Int J Nanomedicine. 2019 Sep;Volume 14:7291–306. doi:10.2147/IJN.S214883

85. Morakul B. Self-nanoemulsifying drug delivery systems (SNEDDS): an advancement technology for oral drug delivery. Pharm Sci Asia. 2020;47(3):205–20. doi:10.29090/psa.2020.03.019.0121

86. Khoshyari S, Mahjub R. Preparation, Box-Behnken Statistical Optimization, and In Vitro Characterization of a Self-nanoemulsifying Drug Delivery System for the Oral Delivery of Budesonide as a Poorly Soluble Drug. Avicenna J Pharm Res. 2020 Jul 6;1(1):24–32. doi:10.34172/ajpr.2020.05

87. Zingale E, Bonaccorso A, D’Amico AG, Lombardo R, D’Agata V, Rautio J, et al. Formulating Resveratrol and Melatonin Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Ocular Administration Using Design of Experiments. Pharmaceutics. 2024 Jan 18;16(1):125. doi:10.3390/pharmaceutics16010125

88. Jha D, Sindhu K, Kumar A, Utwaliya GK, Ranjan H, Kumari N, et al. Optimization of Advance Novel Oral Self-Emulsifying Drug Delivery System (SEDDs) Involving Box-Behnken Design as Statistical Analysis Approach of Nateglinide Drug. J Neonatal Surg. 2025;14(23).

89. Patel A, Shelat P, Lalwani A. Development and Optimization of Solid Self Nanoemulsifying Drug Delivery (S-SNEDDS) Using D-Optimal Design for Improvement of Oral Bioavailability of Amiodarone Hydrochloride. Curr Drug Deliv. 2015 Dec 28;12(6):745–60. doi:10.2174/1567201812666150302122501

90. Usta DY, Timur B, Teksin ZS. Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatment. Eur J Pharm Sci. 2022 Jul;174:106159. doi:10.1016/j.ejps.2022.106159

91. Padhye SG, Nagarsenker MS. Simvastatin Solid Lipid Nanoparticles for Oral Delivery: Formulation Development and In vivo Evaluation. Indian J Pharm Sci. 2013;75(5):591–8. PubMed PMID: 24403661; PubMed Central PMCID: PMC3877522.

92. Jain S, Jain S, Khare P, Gulbake A, Bansal D, Jain SK. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv. 2010 Aug;17(6):443–51. doi:10.3109/10717544.2010.483252

93. Madan JR, Khude PA, Dua K. Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery. Int J Pharm Investig. 2014;4(2):60–4. doi:10.4103/2230-973X.133047 PubMed PMID: 25006550; PubMed Central PMCID: PMC4083535.

94. Shah P, Chavda K, Vyas B, Patel S. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition. Drug Deliv Transl Res. 2021 Jun;11(3):1166–85. doi:10.1007/s13346-020-00839-9

95. Somadasan S, Subramaniyan G, Athisayaraj MS, Sukumaran SK. Central Composite Design: An Optimization Tool for Developing Pharmaceutical Formulations. J Young Pharm. 2024 Aug 23;16(3):400–9. doi:10.5530/jyp.2024.16.52

96. . AKS, . PA, . PChakravarty. Formulation of solid lipid nanoparticles and their applications. J Curr Pharma Res. 2011 Feb 15;1(2):197–203. doi:10.33786/JCPR.2011.v01i02.019

97. Optimization-of-methazolamide-loaded-solid-lipid-nanoparticles-for-ophthalmic-delivery-using-Box-Behnken-design.pdf [Internet]. [cited 2025 Aug 31]. Available from: https://www.researchgate.net/profile/Rui-Li-148/publication/260680850_Optimization_of_methazolamide-loaded_solid_lipid_nanoparticles_for_ophthalmic_delivery_using_Box-Behnken_design/links/53d58fb40cf220632f3d5941/Optimization-of-methazolamide-loaded-solid-lipid-nanoparticles-for-ophthalmic-delivery-using-Box-Behnken-design.pdf

98. Emami J, Mohiti H, Hamishehkar H, Varshosaz J. Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box- Behnken design.

99. Gajra B, Dalwadi C, Patel R. Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design. DARU J Pharm Sci. 2015 Dec;23(1):3. doi:10.1186/s40199-014-0087-0

100. Maddiboyina B, Jhawat V, Nakkala RK, Desu PK, Gandhi S. Design expert assisted formulation, characterization and optimization of microemulsion based solid lipid nanoparticles of repaglinide. Prog Biomater. 2021 Dec;10(4):309–20. doi:10.1007/s40204-021-00174-3

101. Asif A, Desu P, Alavala R, Rao G, Sreeharsha N, Meravanige G. Development, Statistical Optimization and Characterization of Fluvastatin Loaded Solid Lipid Nanoparticles: A 32 Factorial Design Approach. Pharmaceutics. 2022 Mar 8;14(3):584. doi:10.3390/pharmaceutics14030584

102. Dey H, Arya N, Mathur H, Chatterjee N, Jadon R. Exploring the Role of Artificial Intelligence and Machine Learning in Pharmaceutical Formulation Design. Int J Newgen Res Pharm Healthc. 2024 Jun 30;30–41. doi:10.61554/ijnrph.v 2i1.2024.67

103. Dey H, Arya N, Mathur H, Chatterjee N, Jadon R. Exploring the Role of Artificial Intelligence and Machine Learning in Pharmaceutical Formulation Design. Int J Newgen Res Pharm Healthc. 2024 Jun 30;30–41. doi:10.61554/ijnrph.v 2i1.2024.67

Downloads

Published

19-11-2026

Issue

Section

Articles

How to Cite

DESIGN OF EXPERIMENT IN MODERN DRUG DELIVERY: OPTIMIZATION OF LIPID-BASED FORMULATION USING DESIGN-EXPERT. (2026). UNIVERSAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 10(2), 10-20. https://doi.org/10.61114/UJPSR.10.2.2026.10-20